This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Alnylam Pharmaceuticals, Inc.. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: The Innovative Contributions of Lauren Blair Woods
Introduction
Lauren Blair Woods is a prominent inventor based in Sharon, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of RNA interference (RNAi) agents. With a total of 2 patents, her work focuses on addressing disorders related to lipid metabolism.
Latest Patents
One of her latest patents is centered around Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof. This invention relates to RNAi agents, specifically double-stranded RNA (dsRNA) agents, that target the ANGPTL3 gene. The patent outlines methods for using these RNAi agents to inhibit the expression of the ANGPTL3 gene. Additionally, it discusses approaches for preventing and treating ANGPTL3-associated disorders, such as hyperlipidemia and hypertriglyceridemia.
Career Highlights
Lauren is currently associated with Alnylam Pharmaceuticals, Inc., where she continues to advance her research and innovations. Her work is pivotal in the development of therapeutic solutions that leverage RNAi technology.
Collaborations
Some of her notable coworkers include Lucas D BonDurant and Tyler Chickering, who contribute to her innovative projects and research endeavors.
Conclusion
Lauren Blair Woods exemplifies the spirit of innovation in biotechnology through her groundbreaking work on RNAi agents. Her contributions are vital for the advancement of treatments for lipid metabolism disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile